Skip to main content
Premium Trial:

Request an Annual Quote

Febit Joins European Sequencing Technology Alliance

NEW YORK (GenomeWeb News) – Febit has joined a European consortium focused on developing DNA sequencing technologies, and plans to advance its gene capturing technology for use with the group's members.

The Revolutionary Approaches and Devices for Nucleic Acid analysis consortium, involving 16 industry and academic research entities and funded by the European Union with €12 million ($15.1 million), is focused on developing faster, more cost-efficient and targeted approaches in comparative genomics.

The HybSelect technology enables capture of specific DNA regions for high-throughput sequencing, allows researchers to operate next-generation sequencers by directing the sequencing process to the regions of interest to the researcher, Febit CSO Peer Stähler said in a statement.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.